Kevin Bruce Johnson - 15 Oct 2025 Form 4 Insider Report for Tourmaline Bio, Inc. (TRML)

Role
Chief Regulatory Officer
Signature
/s/ Brad Middlekauff, Attorney-in-Fact
Issuer symbol
TRML
Transactions as of
15 Oct 2025
Net transactions value
$0
Form type
4
Filing time
17 Oct 2025, 16:30:06 UTC
Previous filing
29 Jan 2025
Next filing
28 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Johnson Kevin Bruce Chief Regulatory Officer C/O TOURMALINE BIO, INC., 27 WEST 24TH STREET, SUITE 702, NEW YORK /s/ Brad Middlekauff, Attorney-in-Fact 17 Oct 2025 0001994710

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRML Common Stock Gift $0 -6,250 -11% $0.000000 51,584 15 Oct 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares donated to a donor-advised fund, which will use the gifted shares for charitable purposes.